KR920007621A - 배분 패키지내에 있는 겔 형태의 약제학적 조성물 - Google Patents

배분 패키지내에 있는 겔 형태의 약제학적 조성물 Download PDF

Info

Publication number
KR920007621A
KR920007621A KR1019910017216A KR910017216A KR920007621A KR 920007621 A KR920007621 A KR 920007621A KR 1019910017216 A KR1019910017216 A KR 1019910017216A KR 910017216 A KR910017216 A KR 910017216A KR 920007621 A KR920007621 A KR 920007621A
Authority
KR
South Korea
Prior art keywords
agent
composition
active ingredient
gel
pharmaceutical composition
Prior art date
Application number
KR1019910017216A
Other languages
English (en)
Other versions
KR100213513B1 (ko
Inventor
삐에르 따송
비뜨리스 바그뇌
장-루이스 비르
Original Assignee
앙드르제이 레드지옹
소시에떼 데 프로듀이 네슬레 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 앙드르제이 레드지옹, 소시에떼 데 프로듀이 네슬레 소시에떼 아노님 filed Critical 앙드르제이 레드지옹
Publication of KR920007621A publication Critical patent/KR920007621A/ko
Application granted granted Critical
Publication of KR100213513B1 publication Critical patent/KR100213513B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

내용 없음

Description

배분 패키지내에 있는 겔 형태의 약제학적 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 배분 동안에 흘러내리지 않고 감각적으로 수용될 수있는 모조 플라스틱 수 - 분산성 겔에 유효 성분이 균일하게 배분되어 지고, 20 내지 150ml의 내부 용적을 갖고 용적이 5ml를 초과하지 않는 측정 칸막이 및 치료량당 1회 또는 2회의 압박으로 치료량을 배분할 수 있도록 설계된 측정 펌프가 내장되어진 배분기 팩내에 겔이 함유되어 있으며, 배분기의 용량이 적어도 5일의 치료를 위해서는 충분한 용량임을 특징으로 하는, 유효성분의 용액을 경구 투여 겔 시럽으로서 일반적으로 나타낸 패키지 내의 약제학적 조성물.
  2. 제1항에 있어서, 겔이 크산탄검 또는 텍스트란, 셀룰로스 및 이들 유도체, 녹말 및 텍스트린, 카르보머, 아크릴아미드, 아크릴아미딘, 폴리글리콜 및 지방산과의 폴리올의 에스테르로 부터 선택된 겔화제 0.2 내지 5%를 함유하는 조성물.
  3. 제2항에 있어서, 겔화제가 딕소트로프제로서 셀룰로스 유도체 및 마그네슘 알루미노실리케이트로 구성된 혼합물인 조성물.
  4. 제2항에 있어서,겔이 겔화제로서 크산탄검을 함유하는 조성물.
  5. 제1항에 있어서, 유효성분이 개방이거나 밀폐 매트릭스 또는 소포시스템내에서 캡슐화되어 조성물의 감각수용 특성을 개선시킨 조성물.
  6. 제1항에 있어서, 유효성분이 오일-물 형태의 액/액 에멀션 또는 고/액 서스팬션내 분산되어진 조성물.
  7. 제1항에 있어서, 설탕, 감미제, 방부제, 색소 및 향미제를 함유하는 조성물.
  8. 제1항에 있어서, 유효성분이 제산제, 제사제, 향히스타민제, 제토제, 진해제, 항염증제, 진통제/해열제, 기관지 점막 조절제, 진경제, 호흡 자양제/항천식제,전신계 α-교감신경흥분제,완화제,비타민 복합체, 또는 이들 유효 성분들의 혼화성 배합물인 조성물.
  9. 유효성분을 수성매질에 용해시키거나 분산시키고, 용액 또는 분산액을 감미제, 방부제 및 향미제와 혼합시킨다음, 얻어진 혼합물에 교반하면서 겔화제를 첨가한 후, 형성된 겔시럽을 측정칸막이 및 측정 펌프가 내장된 배분기 팩에 채원 넣는것을 특징으로 하는 팩으로 된 약제학적 조성물의 제조방법.
  10. 제9항에 있어서, 유효성분을 수성매질에 용해시키거나 분산시키기 전에, 유효성분을 캡슐화하여 조성물의 감각수용 특성을 개선시키는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910017216A 1990-10-04 1991-10-01 배분 패키지내에 있는 겔 형태의 약제학적 조성물 KR100213513B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90118920 1990-10-04
EP90118920.9 1990-10-04

Publications (2)

Publication Number Publication Date
KR920007621A true KR920007621A (ko) 1992-05-27
KR100213513B1 KR100213513B1 (ko) 1999-08-02

Family

ID=8204572

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910017216A KR100213513B1 (ko) 1990-10-04 1991-10-01 배분 패키지내에 있는 겔 형태의 약제학적 조성물

Country Status (27)

Country Link
US (2) US5300302A (ko)
EP (1) EP0479005B1 (ko)
JP (1) JP3219799B2 (ko)
KR (1) KR100213513B1 (ko)
AT (1) ATE131039T1 (ko)
AU (1) AU643067B2 (ko)
BR (1) BR9104280A (ko)
CA (1) CA2052615C (ko)
DE (1) DE69115210T2 (ko)
DK (1) DK0479005T3 (ko)
DZ (1) DZ1530A1 (ko)
EG (1) EG19906A (ko)
ES (1) ES2081407T3 (ko)
FI (1) FI104947B (ko)
GR (1) GR3018893T3 (ko)
HU (1) HU219222B (ko)
IE (1) IE72146B1 (ko)
IL (1) IL99509A (ko)
MA (1) MA22289A1 (ko)
MX (1) MX9101391A (ko)
MY (1) MY107488A (ko)
NO (1) NO303525B1 (ko)
NZ (1) NZ240068A (ko)
PT (1) PT99143B (ko)
RU (1) RU2093143C1 (ko)
TN (1) TNSN91085A1 (ko)
ZA (1) ZA917627B (ko)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
JPH06172189A (ja) * 1992-08-17 1994-06-21 Bristol Myers Squibb Co 胃腸保護複合剤
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
AU3896395A (en) * 1994-10-11 1996-05-02 James A. Monson Dispensing apparatus for foaming compositions and method
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
ATE197900T1 (de) * 1996-08-15 2000-12-15 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) * 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
KR100399483B1 (ko) * 2000-12-12 2003-09-29 대화제약 주식회사 플로로글루시놀을 유효성분으로 함유하는 신규 진경액제
DE60238193D1 (de) * 2001-06-22 2010-12-16 Pfizer Prod Inc Pharmazeutische zusammensetzungen, enthaltend adsorbate eines arzneimittels in amorpher form
ES2323264T3 (es) * 2001-08-01 2009-07-10 Novartis Ag Composicion para enmascaramiento del sabor.
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
ATE505183T1 (de) * 2001-10-22 2011-04-15 Taro Pharma Ind Den geschmack verdeckende auslaufsichere formulierung
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
ATE450187T1 (de) * 2001-12-06 2009-12-15 Univ Duke Verhinderung von hautlappennekrose in der plastischen chirurgie
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
CN101862292A (zh) * 2002-06-17 2010-10-20 塔罗制药美国公司 布洛芬混悬剂
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP2070551B1 (en) * 2003-01-31 2013-01-16 Simply Thick LLC Process for producing thickened beverages for dysphagia
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
US7201920B2 (en) * 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
CA2565941A1 (en) * 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
US20060148903A1 (en) * 2004-11-24 2006-07-06 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112796A1 (en) * 2005-11-17 2007-05-17 Jung Edward K Research in providing assistance related to health
US20070112589A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware User interface for providing assistance related to health
US8532938B2 (en) * 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US20070119928A1 (en) * 2005-11-17 2007-05-31 Jung Edward K Generating a nutraceutical request from an inventory
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US8297028B2 (en) * 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US20080004909A1 (en) * 2005-11-30 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems related to nutraceuticals
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US8068991B2 (en) * 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
WO2007075378A2 (en) * 2005-12-20 2007-07-05 Searete Llc Control systems for individualized pharmaceutical and nutraceutical selection and packaging
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN101453982B (zh) 2006-05-30 2011-05-04 精达制药公司 两件式内部通道渗透递送系统流动调节器
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
WO2008021133A2 (en) 2006-08-09 2008-02-21 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
KR20080076667A (ko) 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
CA2685936C (en) * 2007-05-07 2016-07-12 Clearly Superior, Inc. Food thickening agent, method for producing food thickening agent
US8001345B2 (en) * 2007-05-10 2011-08-16 Dot Hill Systems Corporation Automatic triggering of backing store re-initialization
US8968786B2 (en) 2007-06-22 2015-03-03 Board Of Regents, The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
WO2010056657A2 (en) 2008-11-16 2010-05-20 Board Of Regents, The Univesity Of Texas System Low viscosity highly concentrated suspensions
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
CN104323981B (zh) 2009-09-28 2019-03-12 精达制药公司 基本稳态药物递送的快速建立和/或终止
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
MY166034A (en) 2010-12-22 2018-05-21 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
JP5638151B2 (ja) 2010-12-23 2014-12-10 パーデュー、ファーマ、リミテッド、パートナーシップ 不正加工抵抗性の（ｔａｍｐｅｒｒｅｓｉｓｔａｎｔ）固形経口剤形
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP2793563B1 (en) * 2011-12-22 2018-06-06 Babolna Bio Ltd. A consumable aqueous gel for use in pest control, a pest control device comprising an aqueous gel, and the use of an aqueous gel in a pest control device and in a method of controlling pests
US20150290131A1 (en) * 2012-10-25 2015-10-15 Nestec S.A. Encapsulated bitter peptides, methods of encapsulating bitter peptides, and nutritional compositions including encapsulated bitter peptides
US8550131B1 (en) 2013-01-02 2013-10-08 Liquid Squeeze, LLC Liquid dispensing device, system and method
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016196851A2 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
PL3319596T3 (pl) * 2015-07-09 2024-04-15 Uniwell Laboratories Llc Farmaceutyczne kompozycje
MX2018014016A (es) 2016-05-16 2019-08-01 Intarcia Therapeutics Inc Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US4155741A (en) * 1974-05-01 1979-05-22 Stauffer Chemical Company Stable suspension system for microencapsulated flowable formulations, and method of preparing stable suspension of microcapsules
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4305933A (en) * 1980-03-10 1981-12-15 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4424055A (en) * 1981-12-18 1984-01-03 Herman Wesley K Irrigation and aspiration syringe
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
USRE32969E (en) * 1982-10-14 1989-06-27 Injectionable visoelastic ophthalmic gel
US4576645A (en) * 1984-12-06 1986-03-18 Block Drug Co., Inc. Whipped gel composition
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package

Also Published As

Publication number Publication date
IE913286A1 (en) 1992-04-08
MX9101391A (es) 1992-04-01
DZ1530A1 (fr) 2002-02-17
ZA917627B (en) 1992-06-24
HU912990D0 (en) 1992-01-28
IL99509A (en) 1995-08-31
NZ240068A (en) 1994-05-26
EP0479005B1 (fr) 1995-12-06
US5505959A (en) 1996-04-09
FI914607A0 (fi) 1991-10-01
US5300302A (en) 1994-04-05
ES2081407T3 (es) 1996-03-01
CA2052615C (en) 2001-01-16
KR100213513B1 (ko) 1999-08-02
CA2052615A1 (en) 1992-04-05
NO913847D0 (no) 1991-10-01
HUT59587A (en) 1992-06-29
RU2093143C1 (ru) 1997-10-20
DK0479005T3 (da) 1996-03-11
DE69115210D1 (de) 1996-01-18
JP3219799B2 (ja) 2001-10-15
IE72146B1 (en) 1997-03-26
AU8458991A (en) 1992-04-09
PT99143A (pt) 1993-12-31
EP0479005A1 (fr) 1992-04-08
FI104947B (fi) 2000-05-15
AU643067B2 (en) 1993-11-04
MA22289A1 (fr) 1992-04-01
JPH04247023A (ja) 1992-09-03
NO913847L (no) 1992-04-06
TNSN91085A1 (fr) 1992-10-25
EG19906A (fr) 1996-05-31
HU219222B (en) 2001-03-28
ATE131039T1 (de) 1995-12-15
MY107488A (en) 1995-12-30
GR3018893T3 (en) 1996-05-31
FI914607A (fi) 1992-04-05
DE69115210T2 (de) 1996-05-09
IL99509A0 (en) 1992-08-18
PT99143B (pt) 1999-04-30
NO303525B1 (no) 1998-07-27
BR9104280A (pt) 1992-06-02

Similar Documents

Publication Publication Date Title
KR920007621A (ko) 배분 패키지내에 있는 겔 형태의 약제학적 조성물
US4794117A (en) Process for solubilizing active ingredients and the thus-obtained pharmaceutical compositions
JP2879917B2 (ja) 経口用医薬ゲル組成物
KR100554811B1 (ko) 약학제형
JPS61151125A (ja) ジヒドロコデイン／イブプロフエン薬剤組成物及び方法
JP3597333B2 (ja) 急性鼻炎を処置するための医薬製剤
CN105395469A (zh) 活性物质的冻干组合物
MXPA97002456A (en) Liquid antiacidal compositions containing calcium carbonate and possibly simeticone as active compounds and monobasic potassium phosphate and potassium bicarbonate as regula
EP0843998B1 (en) Oral pharmaceutical composition having antipyretic, analgesic and antiinflammatory activity
JPS63297316A (ja) 毛髪成長の刺激、増進ならびに回復のための製品及びその方法
JPS60115516A (ja) 自律神経系用薬剤
DE69401502D1 (de) Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält
PT1637165E (pt) Emulsões medicinais refrescantes
US20040219229A1 (en) Migraine relief composition and methods of using and forming same
FR2993458A1 (fr) Preparation pharmaceutique liquide pour administration orale a base de sirop d'agave biologique a indice glycemique reduit
JPS6219535A (ja) リゾチ−ムシロツプ剤
US4241047A (en) Novel medicinal composition for the treatment of biliary lithiasis
HU228857B1 (en) Stable formulation containing fumagillin
CN1331462C (zh) 龙血竭总黄酮自微乳化液
CN113350266B (zh) 一种具有抗菌作用的口腔黏膜修复原位温敏凝胶
ZA200101153B (en) Transdermally delivered aspirin.
JPS62126130A (ja) 動物用医薬組成物
JPS597115A (ja) 消炎鎮痛外用剤
US11617795B2 (en) Pharmaceutical syrup formulation or suspension
JPH0334919A (ja) 浴用剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090508

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee